MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Survival

Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study

European Journal of Cardio-Throacic Surgery 2017 April [Epub ahead of print] [Link] Marulli G, Breda C, Fontana P, Ratto GB, Leoncini G, Alloisio M, Infante M, Luzzi L, Paladini P, Oliaro A, Ruffini E, Benvenuti MR, Pariscenti G, Spaggiari L, Casiraghi M, Rusca M, Carbognani P, Ampollini L, Facciolo F, Leuzzi G, Mucilli F, Camplese […]

Comments Off on Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study

Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.

Acta Chirugica Belgica 2017 June [Link] Domen A, De Laet C, Vanderbruggen W, Gielis J, Hendriks JM, Lauwers P, Janssens A, Hiddinga B, Van Meerbeeck JP, Van Schil PE Abstract BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare but aggressive neoplasm that typically originates from the mesothelial surfaces of the pleural cavity. Exposure to asbestos […]

Comments Off on Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.

Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.

Asia-Pacific Journal of Clinical Oncology 2017 March 29 [Epub ahead of print] [

Comments Off on Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.

Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.

Journal of Thoracic Oncology 2017 March [Epub ahead of print] [Link] Shaikh F, Zauderer MG, von Reibnitz D, Wu AJ, Yorke ED, Foster A, Shi W, Zhang Z, Adusumilli PS, Rosenzweig KE, Krug LM, Rusch VW, Rimner A Abstract INTRODUCTION: Higher target conformity and better sparing of organs at risk with modern radiotherapy (RT) may […]

Comments Off on Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.

Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma

The European Respiratory Journal 2017 March 15 [Print 2017] [Link] de Perrot M, Dong Z, Bradbury P, Patsios D, Keshavjee S, Leighl NB, Hope A, Feld R, Cho J Abstract Tumour thickness was assessed to determine if this parameter could refine patients’ selection for multimodality therapy in malignant pleural mesothelioma.We reviewed 65 consecutive treatment-naïve malignant […]

Comments Off on Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma

Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years

The Annals of Thoracic Surgery 2017 March [Epub November 5] [Link] Friedberg JS, Simone CB 2nd, Culligan MJ, Barsky AR, Doucette A, McNulty S, Hahn SM, Alley E, Sterman DH, Glatstein E, Cengel KA Abstract BACKGROUND: The purpose of this study was to assess survival for patients with malignant pleural mesothelioma (MPM), epithelial subtype, utilizing […]

Comments Off on Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years

Life Expectancy in Pleural and Peritoneal Mesothelioma

Lung Cancer International [Epub 2017 January] [Link] Shavelle R, Vavra-Musser K, Lee J, Brooks J Abstract Background. Mesothelioma is a rare cancer with a historically dire prognosis. We sought to calculate life expectancies for patients with pleural or peritoneal mesothelioma, both at time of diagnosis and several years later, and to examine whether survival has […]

Comments Off on Life Expectancy in Pleural and Peritoneal Mesothelioma

Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit

European Journal of Cancer 2017 February [Epub ahead of print] [Link] Papadatos-Pastos D, Roda D, De Miguel Luken MJ, Petruckevitch A, Jalil A, Capelan M, Michalarea V, Lima J, Diamantis N, Bhosle J, Molife LR, Banerji U, de Bono JS, Popat S, O’Brien ME, Yap TA. Abstract BACKGROUND: We have previously reported a prognostic score […]

Comments Off on Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Oncologist 2017 February 10 [Epub ahead of print] [Link] Wang X1, Wang X, Hodgson L, George SL, Sargent DJ, Foster NR, Kishor Ganti A, Stinchcombe TE, Crawford J, Kratzke R, Adjei AA, Kindler HL, Vokes EE, Pang H Abstract PURPOSE: The aim of this study was to investigate whether progression-free survival (PFS) can be considered […]

Comments Off on Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival

European Journal of Surgical Oncology 2017 Janury 29 [Epub ahead of print] [Link] Sugarbaker PH, Chang D Abstract PURPOSE: Malignant peritoneal mesothelioma (MPM) is a rare disease with about 300 new cases per year in the USA. Its natural history is described as local progression within the peritoneal space in the absence of liver metastases […]

Comments Off on Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival